Results 41 to 50 of about 99,435 (247)
Gestational trophoblastic tumours and non-neoplastic trophoblastic lesions: morphology and immunocytochemistry to refine the diagnosis [PDF]
, 2019 Gestational trophoblastic disease (GTD) is generally subclassified into hydatidiform moles (HM), Gestational trophoblastic tumours (GTTs) and non-neoplastic trophoblastic lesions. GTT represent a spectrum of neoplasms that originate from the extravillous
Sebire, NJ, Kaur, B
core +1 more source
Uterine rupture secondary to undiagnosed placental site trophoblastic tumor: case report
, 2022 Placental site trophoblastic tumor is a rare and malignant form of gestational trophoblastic disease. Its incidence rate is 1/50.000-100.000 pregnancies and accounts for less than 3% of all cases of gestational trophoblastic disease.
Arthur Antolini Tavares +3 more
core +1 more source
Molecular and immunohistochemical characteristics of complete hydatidiform moles
Balkan Journal of Medical Genetics, 2017 Molar pregnancy is a gestational trophoblastic disease that belongs to the category of precancerous lesions. On the other end of the spectrum are gestational trophoblastic neoplasms such as invasive mole, choriocarcinoma, placental site trophoblastic ...
Kubelka-Sabit KB +6 more
doaj +1 more source
, 2016 Gestational trophoblastic neoplasms (GTN) originate from placental tissue and usually metastasizes because of its propensity for early vascular invasion. Intracranial metastases are relatively uncommon.
Serkan Uysal +4 more
core +1 more source
High risk gestational trophoblastic diseases: Diagnosis and primary management with EMACO chemotherapy [PDF]
, 2015 Gestational trophoblastic disease (GTD) is characterized by abnormal proliferation of pregnancy associated trophoblastic tissue with malignant potential.
Kadam R. Priyanka, Dave S. Pariseema
core +1 more source
FEBS Open Bio, EarlyView.The cytoskeleton‐mediated transport of mitochondria via tunnelling nanotubes restores respiration, increases ATP production, rescues cells from apoptosis, activates the AKT/mTOR signalling pathway, promotes cell migration and invasiveness, contributes to cancer progression and treatment resistance.
Stanislava Martínková, Jan Trnka
wiley +1 more source
Confusing trophoblastic lesion (placental site nodule): case report [PDF]
, 2014 İnönü Üniversitesi Sağlık Bilimleri Dergisi 2014; 3 (2): 26-27 ss.Plasental site nodül, genellikle üreme çağındaki kadınların, küretaj materyallerinde, serviks biyopsilerinde ve histerektomi materyallerinde, rastlantısal olarak karşımıza çıkar ...
Azatçam, Meltem, Altun, Eren
core +1 more source
Advanced Science, EarlyView.NSUN2 and m5C decline in URSA villous tissues. Trophoblast Nsun2 ablation disrupts macrophage‐mediated maternal‐fetal tolerance and triggers embryo resorption. Mechanistically, NSUN2‐YBX1 axis stabilizes m5C‐modified TGFB1 mRNA to maintain TGF‐β1 secretion and M2 polarization, and restoring this signaling rescues maternal‐fetal immune tolerance to ...
Xiaoxiao Zhu +10 more
wiley +1 more source
Oncogenic HrasG12V expression plus knockdown of Cdkn2a using ecotropic lentiviral vectors induces high-grade endometrial stromal sarcoma. [PDF]
PLoS ONE, 2017 The uterine corpus represents the most common site for tumour development in the female genital system. Uterine neoplasms are categorised as epithelial, mesenchymal, mixed epithelial-mesenchymal or trophoblastic tumours. In this study we employed a mouse
Laura P Brandt +5 more
doaj +1 more source
Advanced Science, EarlyView.TROP2 is identified as a novel tumor‐selective lysosomal‐targeting receptor with established clinical relevance. TROP2‐targeting chimeras (TRTACs) are developed by genetically fusing a TROP2‐binding nanobody to nanobodies against specific target proteins.
Luping Chen +10 more
wiley +1 more source